This September, SHIFTBIO was honored to once again participate in the prestigious Exosome-Based Therapeutic Development Summit held in Boston. For the third consecutive year, SHIFTBIO’s co-founder and co-CEO, Gihoon Nam, delivered a compelling presentation highlighting our groundbreaking Natural Drug Delivery Platform and our vision for the future of drug delivery.
The summit provided an invaluable opportunity for us to engage with cutting-edge technologies and expand our professional network within the global community. These interactions are crucial as we continue to lead the paradigm shift in global drug development.
We extend our heartfelt thanks to all the organizers and participants for another insightful event. SHIFTBIO is committed to seizing every opportunity to advance and innovate within the industry.
This September, SHIFTBIO was honored to once again participate in the prestigious Exosome-Based Therapeutic Development Summit held in Boston. For the third consecutive year, SHIFTBIO’s co-founder and co-CEO, Gihoon Nam, delivered a compelling presentation highlighting our groundbreaking Natural Drug Delivery Platform and our vision for the future of drug delivery.
The summit provided an invaluable opportunity for us to engage with cutting-edge technologies and expand our professional network within the global community. These interactions are crucial as we continue to lead the paradigm shift in global drug development.
We extend our heartfelt thanks to all the organizers and participants for another insightful event. SHIFTBIO is committed to seizing every opportunity to advance and innovate within the industry.